OpenAlex
PricingAboutJobs
Log inGet started
Work

Should the Use of Selective Serotonin Reuptake Inhibitors in Child and Adolescent Depression Be Banned?

HTML

Year: 2006
Type: review
Source: Psychotherapy and Psychosomatics
DOI: 10.1159/000096360
Author: David Cohen
Institutions: Pitié-Salpêtrière Hospital, Université Pierre-et-Marie-Curie
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: selective serotonin reuptake inhibitors, child and adolescent depression, adolescent depression, fluoxetine, paroxetine, sertraline, citalopram, antidepressant efficacy, drug safety, suicide risk, placebo response, age-related drug effects, clinical guidelines, second-line therapy
SDG: Good health and well-being

Open Access status: closed

Funders: Sanofi, National Institutes of Health
OpenAlex ID: W2153612952
FWCI: 0.707
Cites: 72
Cited by: 62
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security